Balance Sheet
Cash Flow Statement
AmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for MediWound (MDWD) over the last 13 years, with Q3 2025 value amounting to $30.5 million.

  • MediWound's Cash from Financing Activities rose 4739.97% to $30.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.2 million, marking a year-over-year increase of 5327.11%. This contributed to the annual value of $19.4 million for FY2024, which is 1537.29% down from last year.
  • Latest data reveals that MediWound reported Cash from Financing Activities of $30.5 million as of Q3 2025, which was up 4739.97% from $549000.0 recorded in Q2 2025.
  • In the past 5 years, MediWound's Cash from Financing Activities ranged from a high of $30.5 million in Q3 2025 and a low of -$728000.0 during Q2 2022
  • Moreover, its 5-year median value for Cash from Financing Activities was -$174000.0 (2021), whereas its average is $5.8 million.
  • Over the last 5 years, MediWound's Cash from Financing Activities had its largest YoY gain of 455442.48% in 2021, and its largest YoY loss of 80800.0% in 2021.
  • MediWound's Cash from Financing Activities (Quarter) stood at -$177000.0 in 2021, then plummeted by 311.3% to -$728000.0 in 2022, then surged by 71.98% to -$204000.0 in 2023, then plummeted by 151.47% to -$513000.0 in 2024, then skyrocketed by 6050.29% to $30.5 million in 2025.
  • Its Cash from Financing Activities stands at $30.5 million for Q3 2025, versus $549000.0 for Q2 2025 and -$362000.0 for Q1 2025.